MTHFR (Methylenetetrahydrofolate Reductase): What They Mean for Brain, Heart, Liver, and Perimenopause Health
- Jacki Meinhardt
- 3 days ago
- 3 min read
If you have tested positive for Methylenetetrahydrofolate Reductase (MTHFR) C677T or MTHFR A1298C, you may be wondering:
Is this serious?
Does this affect my brain?
Should I be worried about heart disease?
What does this mean for perimenopause?
Let’s walk through it clearly.
What Is the MTHFR Gene?
The MTHFR gene helps your body use folate (vitamin B9).
Folate is needed to:
Make neurotransmitters
Repair DNA
Lower homocysteine
Support detox pathways
Support hormone metabolism
Two common gene variations are:
C677T
A1298C
These are common. Up to 40–60% of people carry at least one variant.
Having a variant does not mean you are sick. It means your enzyme may work less efficiently.
How MTHFR Variants Affect Methylation
MTHFR converts folate into its active form (5-MTHF).
If the enzyme works slower:
Active folate production drops
Homocysteine may rise
High homocysteine is associated with:
Cardiovascular disease
Stroke
Cognitive decline
(Ref: American Heart Association; National Institutes of Health Office of Dietary Supplements)
The gene itself is not the danger. Elevated homocysteine is the concern.
MTHFR and Brain Health
Your brain depends on methylation to produce:
Serotonin
Dopamine
Norepinephrine
Research shows elevated homocysteine is linked to:
Increased stroke risk
Vascular dementia
Cognitive decline
(Smith et al., PLOS One, 2010)
Healthy methylation supports:
Mood stability
Focus
Long-term brain protection
This is especially important in midlife.
MTHFR and Cardiovascular Health
Homocysteine can irritate the lining of blood vessels.
Over time this may:
Damage the endothelium
Increase clot risk
Raise stroke risk
The American Heart Association recognizes elevated homocysteine as associated with cardiovascular disease, though it is not the only risk factor.
This is why testing homocysteine matters more than fearing the gene.
MTHFR and Liver Health
Your liver uses methylation to:
Process toxins
Make phosphatidylcholine
Support bile flow
Clear estrogen
Low folate status has been associated with fatty liver risk in some studies.
(Ref: NIH Office of Dietary Supplements; European Journal of Clinical Nutrition)
Healthy methylation supports liver detox pathways.
MTHFR and Perimenopause
Perimenopause brings hormone shifts.
Estrogen metabolism requires proper methylation.
If methylation is sluggish, women may experience:
Brain fog
Mood swings
Estrogen dominance symptoms
Increased vascular risk
Midlife is also when cardiovascular risk begins to rise in women.
This makes checking homocysteine and B vitamin status especially important during perimenopause.
Patient-Friendly Lab Checklist
If you have MTHFR C677T or A1298C, here are labs worth discussing with your provider:
Core Labs
☐ Homocysteine (Goal often 5–8 µmol/L)
☐ Vitamin B12
☐ Folate (RBC folate preferred)
☐ Vitamin B6
Cardiovascular Support
☐ ApoB
☐ Lipid panel
☐ hs-CRP
Hormone + Liver Support (Perimenopause)
☐ Estradiol
☐ Progesterone
☐ Liver enzymes (AST, ALT)
The most important number is homocysteine.
If homocysteine is normal, your methylation is likely functioning well, even if you carry a variant.
What You Can Do
Support methylation with:
Folate-rich foods (leafy greens, beans)
Adequate B12 intake
B6 and riboflavin
Choline
Exercise
Good sleep
Insulin balance
Genetics provide information. Lifestyle drives outcomes.
Final Takeaway
MTHFR C677T and A1298C are common gene variants.
They can affect:
Brain chemistry
Blood vessel health
Liver detox
Hormone metabolism
But the gene alone does not determine your future.
The key is testing, understanding your labs, and supporting your biology.
Knowledge gives you control.
Research folate and homocysteine support here: https://us.fullscript.com/welcome/jmeinhardt
References
National Institutes of Health Office of Dietary Supplements – Folate Fact Sheet
American Heart Association – Homocysteine and Cardiovascular Disease
Smith AD et al. Homocysteine-lowering by B vitamins and cognitive decline. PLOS One. 2010.






Comments